A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small ...
Recently published research shows that Salmonella caused the highest number of multi-state intestinal disease outbreaks in 2023. The report from the Centers for Disease Control and Prevention found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results